Cigna Corporation

NYSE:CI

364.72 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988198719861985
Revenue 195,187180,642174,272160,577153,74348,56942,04339,66837,87634,91432,38029,11921,99821,25318,41419,10117,62316,54716,68418,17618,80819,34819,11519,99418,78121,43720,03818,95018,95518,39213,71213,92414,29513,98611,4940000
Cost of Revenue 36,28732,20633,56232,71030,81927,528000000000000000000000000000000000
Gross Profit 158,900148,436140,710127,867122,92421,04142,04339,66837,87634,91432,38029,11921,99821,25318,41419,10117,62316,54716,68418,17618,80819,34819,11519,99418,78121,43720,03818,95018,95518,39213,71213,92414,29513,98611,4940000
Gross Profit Ratio 0.8140.8220.8070.7960.80.433111111111111111111111111111110000
Reseach & Development Expenses 000000000000000000000000000000000000000
General & Administrative Expenses 0000011,9349,8310007,56605,9015,7445,4505,53500000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000000000000
SG&A 14,82213,18613,03014,07214,05311,9349,8319,750007,56605,9015,7445,4505,53500000000000000000000000
Other Expenses -149,944-139,767-301,983-271,581-264,34132,55628,03336,75034,54931,61030,20426,64214,08813,58211,06613,18415,99014,81614,891-15,940-17,905-19,918-17,618-18,497-16,487-19,427-18,388-17,349-18,704-17,587-13,547-13,771-13,715-13,622-10,798570.1833700.9-854.9
Operating Expenses 149,94413,186-288,953-257,509-250,28844,49037,86436,75034,54931,61030,20426,64219,98919,32616,51618,71915,99014,81614,891-15,940-17,905-19,918-17,618-18,497-16,487-19,427-18,388-17,349-18,704-17,587-13,547-13,771-13,715-13,622-10,798570.1833700.9-854.9
Operating Income 5,1649,5038,3528,714-96,5454,0704,3143,0033,3443,3122,1762,4762,1692,0481,8963821,6261,7311,7932,236903-5701,4971,4972,2942,0101,6501,601251805165153580364696570.1833700.9-854.9
Operating Income Ratio 0.0260.0530.0480.054-0.6280.0840.1030.0760.0880.0950.0670.0850.0990.0960.1030.020.0920.1050.1070.1230.048-0.0290.0780.0750.1220.0940.0820.0840.0130.0440.0120.0110.0410.0260.0610000
Total Other Income Expenses Net 5,513-1,150121,463107,800103,1155,4792,9792,9662,5362,2392,0271,7441,7011,6801,4022,0052,6152,9062,9893,9403,3673,6113,7483,6663,7025,0245,1035,0345,0414,480000000000
Income Before Tax 5,5138,3536,78210,8686,5703,5813,6062,9793,3273,3042,1762,4771,9681,8701,8983781,6311,7311,7932,375903-5691,4971,4971,2192,0101,6501,601251805000000000
Income Before Tax Ratio 0.0280.0460.0390.0680.0430.0740.0860.0750.0880.0950.0670.0850.0890.0880.1030.020.0930.1050.1070.1310.048-0.0290.0780.0750.0650.0940.0820.0840.0130.044000000000
Income Tax Expense 1411,6071,3672,3791,4509351,3741,1361,2501,21069885364052159490511572517798283-17250851052071856454540251-69-1581313413497.9147.4166-0.3
Net Income 5,1646,7045,3708,4585,1042,6372,2371,8672,0942,1021,4761,6231,3271,3451,3022921,1151,1551,6251,438668-3989899871,7741,2921,0861,056211554234311449330562472.2685.6534.9-854.6
Net Income Ratio 0.0260.0370.0310.0530.0330.0540.0530.0470.0550.060.0460.0560.060.0630.0710.0150.0630.070.0970.0790.036-0.0210.0520.0490.0940.060.0540.0560.0110.030.0170.0220.0310.0240.0490000
EPS 17.5721.6615.8723.1713.5810.699.177.318.177.975.285.74.654.694.751.053.943.494.253.511.51-0.942.081.963.042.041.641.540.320.850.360.480.70.480.780.670.960.78-1.38
EPS Diluted 17.3921.4115.7322.9613.4410.699.177.198.047.835.185.614.594.654.731.053.873.434.173.481.5-0.942.081.9532.021.631.540.320.850.360.480.70.480.780.670.960.78-1.38
EBITDA 5,16412,44011,27511,516-92,8944,7654,4293,6133,9293,9003,0353,0362,5142,3402,1646261,8201,9352,3632,4661,197-3491,7411,7302,5192,3281,9051,601251805165153580364696570.1833700.9-854.9
EBITDA Ratio 0.0260.0690.0650.072-0.6040.0980.1050.0910.1040.1120.0940.1040.1140.110.1180.0330.1030.1170.1420.1360.064-0.0180.0910.0870.1340.1090.0950.0840.0130.0440.0120.0110.0410.0260.0610000